NEDD4–Mediated GSNOR Degradation Aggravates Cardiac Hypertrophy and Dysfunction
Circulation Research · 14.02.2025 · 136 (4) · 422-438
DOI: 10.1161/circresaha.124.324872 ↗Kurz gefasst
Fachartikel in der Zeitschrift Circulation Research, erschienen am 14.02.2025. Verfasst von Xin Tang und 21 weiteren Autor:innen. Beteiligte Einrichtung: Key Laboratory of Drug Targets and Translational Medicine for Cardio-cerebrovascular Diseases, Key Laboratory of Targeted Intervention of Cardiovascu…. Hauptthemen laut MEDLINE: Nedd4 Ubiquitin Protein Ligases, Cardiomegaly. Die Arbeit wurde bisher 23-mal zitiert (Crossref) und nennt 49 Literaturangaben.
Abstract (Originalsprache)
BACKGROUND: The decrease in S-nitrosoglutathione reductase (GSNOR) leads to an elevation of S-nitrosylation, thereby exacerbating the progression of cardiomyopathy in response to hemodynamic stress. However, the mechanisms under GSNOR decrease remain unclear. Here, we identify NEDD4 (neuronal precursor cell expressed developmentally downregulated 4) as a novel molecule that plays a crucial role in the pathogenesis of pressure overload–induced cardiac hypertrophy, by modulating GSNOR levels, thereby demonstrating significant therapeutic potential. METHODS: Protein synthesis and degradation inhibitors were used to verify the reasons for the decrease in GSNOR. Mass spectrometry and database filtering were used to uncover NEDD4, the E3 Ub (ubiquitin) ligase, involved in GSNOR decrease. NEDD4 cardiomyocyte-specific deficiency mice were used to evaluate the role of NEDD4 and NEDD4–induced ubiquitination of GSNOR in cardiac hypertrophy in vivo. Both IBM (indolebutenate methyl ester derivatives), a highly specific NEDD4 inhibitor, and indole-3-carbinol, a NEDD4 inhibitor currently undergoing phase 2 clinical trial, were used to effectively suppress the NEDD4/GSNOR axis. RESULTS: GSNOR protein levels were reduced, while mRNA levels remained unchanged in myocardium samples from hypertrophic patients and transverse aortic constriction–induced mice, indicating GSNOR is regulated by ubiquitination. NEDD4, an E3 Ub ligase, was associated with GSNOR ubiquitination, which exhibited significantly higher expression levels in hypertrophic myocardial samples. Moreover, either the NEDD4 enzyme-dead mutant or GSNOR nonubiquitylated mutant decreased GSNOR ubiquitination and inhibited cardiac hypertrophic growth. Cardiomyocyte-specific NEDD4 deficiency inhibited cardiac hypertrophy in vitro and in vivo. NEDD4 inhibitor IBM effectively suppressed GSNOR ubiquitination and cardiac hypertrophy. Clinically, indole-3-carbinol, a NEDD4 inhibitor in phase II clinical trials used as an antitumor drug, demonstrated comparable efficacy. CONCLUSIONS: Our findings showed that upregulated NEDD4 leads to GSNOR ubiquitination and subsequent degradation, thereby facilitating the progression of cardiac hypertrophy. NEDD4 inhibitors may serve as a potential therapeutic strategy for the treatment of cardiac hypertrophy and heart failure.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Key Laboratory of Drug Targets and Translational Medicine for Cardio-cerebrovascular Diseases, Key Laboratory of Targeted Intervention of Cardiovascular Disease, Collaborative Innovation Center for Cardiovascular Diseas…
- Medical Basic Research Innovation Center for Cardiovascular and Cerebrovascular Diseases, Ministry of Education, Nanjing Medical University, Nanjing, Jiangsu, China (X.T., X.L., X.S., Y. Zhang, Y. Zu, Q.F., L.H., S.S.,…
- State Key Laboratory of Frigid Zone Cardiovascular Diseases (SKLFZCD), Department of Pharmacology (State-Province Key Laboratories of Biomedicine-Pharmaceutics of China), College of Pharmacy, Key Laboratory of Cardiovas…
- Department of Forensic Medicine, Nanjing Medical University, China (F.C.).
- State Key Laboratory of Frigid Zone Cardiovascular Diseases, Cardiovascular Research Institute and Department of Cardiology, General Hospital of Northern Theater Command, Shenyang, China (C.H.Y., Yaling Han).
- Department of Thoracic and Cardiovascular Surgery, Nanjing First Hospital, Nanjing Medical University, China (X.C., Y.X., W.C.).
ORCID-Profile: Yan Zhang, Lulu Hu, Shixiu Sun, Zhiren Zhang, Feng Chen, ChengHui Yan, Yueyue Xu, Yongfeng Shao, Jiaxi Gu, Jun Pu, Bo Yu, Yaling Han, Liping Xie, Yong Ji
Zitieren
APA
Tang, X., Liu, X., Sha, X., Zhang, Y., Zu, Y., Fan, Q., Hu, L., Sun, S., Zhang, Z., Chen, F., Yan, C., Chen, X., Xu, Y., Chen, W., Shao, Y., Gu, J., Pu, J., Yu, B., Han, Y., …, & Ji, Y. (2025). NEDD4–Mediated GSNOR Degradation Aggravates Cardiac Hypertrophy and Dysfunction. Circulation Research, 136(4), 422-438. https://doi.org/10.1161/circresaha.124.324872
Vancouver
Tang X, Liu X, Sha X, Zhang Y, Zu Y, Fan Q, et al. NEDD4–Mediated GSNOR Degradation Aggravates Cardiac Hypertrophy and Dysfunction. Circulation Research. 2025;136(4):422-438. doi:10.1161/circresaha.124.324872
BibTeX
@article{Tang2025,
author = {Tang, Xin and Liu, Xiameng and Sha, Xinqi and Zhang, Yan and Zu, Yan and Fan, Qiyao and Hu, Lulu and Sun, Shixiu and Zhang, Zhiren and Chen, Feng and Yan, ChengHui and Chen, Xin and Xu, Yueyue and Chen, Wen and Shao, Yongfeng and Gu, Jiaxi and Pu, Jun and Yu, Bo and Han, Yaling and Xie, Liping and Han, Yi and Ji, Yong},
title = {NEDD4–Mediated GSNOR Degradation Aggravates Cardiac Hypertrophy and Dysfunction},
journal = {Circulation Research},
year = {2025},
volume = {136},
number = {4},
pages = {422--438},
doi = {10.1161/circresaha.124.324872}
}
EUVIMED